A Randomized, Double Blind, Third Party Open, Placebo Controlled Multi-Center Study Of Efficacy, Safety And Tolerability Of Pf-06743649 In Gout Subjects

Trial Profile

A Randomized, Double Blind, Third Party Open, Placebo Controlled Multi-Center Study Of Efficacy, Safety And Tolerability Of Pf-06743649 In Gout Subjects

Discontinued
Phase of Trial: Phase I

Latest Information Update: 16 Nov 2016

At a glance

  • Drugs PF 6743649 (Primary)
  • Indications Gout
  • Focus Therapeutic Use
  • Sponsors Pfizer
  • Most Recent Events

    • 08 Mar 2015 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov record.
    • 23 Dec 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
    • 24 Nov 2014 Planned End Date changed from 1 Jan 2015 to 1 Dec 2014 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top